Steroids and Major League Baseball Mitchell Grossman Timothy Kimsey Joshua Moreen Matthew Owings1TABLE OF CONTENTS INTRODUCTION.....................................................................................................................2 PERFORMANCE ENHANCING DRUGS IN SPORTS.........................................................2 STEROID TESTING IN BASEBALL .....................................................................................2 ECONOMIC RESULTS OF STERIOD USE ..........................................................................3 The “Game” of Using Steroids..............................................................................................3 Benefit of Increased Offensive Production to Players..........................................................4 Increase in OPS with Steroids .............................................................................................5 Increase in Salary with Steroids ..........................................................................................6 Increase in NPV Over Lifetime Due To Steroids ..................................................................6 Benefit of Increased Offensive Production to League..........................................................7 Average Team Revenue Increases........................................................................................7 Economic Punishment for Steroid Use .................................................................................8 Average Team Revenue Losses Due To Scandal...................................................................9 CRIME AND PUNISHMENT................................................................................................10 Game Under Current Punishment Scheme........................................................................11 Game Under New Punishment Scheme..............................................................................11 Sensitivity to the Probability of Being Caught ...................................................................12 Accounting for Dynamic Player Strategy...........................................................................12 THE ROLE OF CONGRESS .................................................................................................13 CONCLUSION .......................................................................................................................14 EXHIBITS...............................................................................................................................15 Exhibit A: Calculation of Player’s NPV of Using Steroids ................................................15 Exhibit B: 2001 MLB Franchise Revenues ($ Thousands) ................................................16 Exhibit C: MLB Average Franchise Post-Scandal Revenue Calculation..........................17 Exhibit D: Payouts for Average MLB Franchises..............................................................17 Exhibit E: Player NPV Calculations...................................................................................18 BIBLIOGRAPHY ...................................................................................................................202INTRODUCTION The crack of the bat, the smell of the grass…there’s just something about baseball. Most Americans have grown up with the game, sharing a passion that spans generations, geography and social class. To many of us, baseball, especially its history, is representative of a simpler and purer world. That view has been under assault from the Steroids Era of 1994 to 2004 and its repercussions on the game. As fans, America enjoyed the jump in offensive statistics and Mark McGwire and Sammy Sosa’s chase of the great Roger Maris. However, the sudden offensive explosion raised questions about how these numbers were being achieved. The rumors of steroid use among players finally began to explode with the revelation in 1998 that McGwire was taking androstenedione. As baseball finally begins to get serious about its steroid problem, this paper investigates the economic motivations for steroid use in baseball and the expected effects of different anti-doping policies and punishment regimes. PERFORMANCE ENHANCING DRUGS IN SPORTS The use of performance enhancing drugs has tracked the rise and fall of mass-entertainment sports. Going back to the ancient Olympics and Roman times, athletes used performance enhancing herbs and mushrooms in order to improve their performance in competition by making them faster, stronger or braver (Osborne 2005). Use of performance enhancing drugs seems to have drastically diminished in the post-Roman, pre-modern era in Europe until the rebirth of spectator sports in the U.K. in the nineteenth century (Osborne 2005). This timeline seems to suggest a correlation between the use of performance enhancing drugs in sports and the presence of commercial or other rewards. In ancient Greece, as in modern times, these rewards went to the athletes or those associated with them (Osborne 2005). If we assume that the role of the Roman circus was to distract the population from strife and bad government, then any improvement in the production of athletes involved in the contests would serve to only enhance the entertainment and distraction (Osborne 2005). By 1928, the IAAF, track and field’s international governing body, enacted the first modern anti-doping rules in modern sports (Osborne 2005). STEROID TESTING IN BASEBALL Steroids finally made it to baseball’s banned substance list in 1991, however testing for major league players did not begin until the 2003 season. Evidence of steroid use was rampant. Offensive numbers were way up. In 1996, the Orioles, Mariners, and A's all broke their single season home run records. 1998 saw Mark McGwire destroy Roger Maris’ home run record, closely followed by Cubs slugger Sammy Sosa. Three years later, Barry Bonds broke McGwire’s home run record. A change in the nature and frequency of injuries also pointed to increased steroid use. The number of players on the Disabled List (DL) increased 31%, from 266 in 1989 to 349 in 1998, and the average stay on the DL increased 13% over the same period (Assael 2005). Furthermore, the nature of injuries changed to ailments resulting from oversized muscles ripping away from bones that could no longer support them (Assael